Substance Use Disorder Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies - MediciNova, Omeros Corp., KemPharm, InterveXion Therapeutics, and Others

DelveInsight's "Substance Use Disorder Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Substance Use Disorder Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Substance Use Disorder market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Substance Use Disorder: An Overview
Substance use disorder (SUD), also called Drug addiction, is a condition when a person's use of alcohol and/or drug substances leads to impairment, such as health problems, disability or problems at work, school or home. Addiction represents the most severe form of this disorder.

The exact cause of substance use disorder is not known. A person's genes, drug action, peer pressure, emotional distress, anxiety, depression, and environmental stress can all be factors for Substance Use Disorder. Many who develop a substance use problem have depression, attention deficit disorder, post-traumatic stress disorder, or another mental problem. A stressful or chaotic lifestyle and low self-esteem are also common.

Substance Use Disorder Market Key Facts
• According to the American Addiction Centers, in 2017, approximately four percent of the American adolescent population aged 12-17 suffered from a substance use disorder. About 1.8% of adolescents had an alcohol use disorder, and about three percent of this population suffered from an illicit drug use disorder.
• According to the study conducted by Polak et al. (2015), gender differences exist in the development, course, and treatment of substance use disorders (SUD). Men are 1.9-2.2 times more likely to have SUD; women are more vulnerable to negative medical and psychosocial consequences of alcohol and other drugs.
• As per the study by Carney et al. (2020), alcohol abuse was the most common lifetime SUD diagnosis (9.3%), followed by alcohol dependence (7.3%) and drug abuse.

Request for Sample PDF:
https://www.delveinsight.com/report-store/substance-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Substance Use Disorder Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Substance Use Disorder market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Substance Use Disorder market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Download the Sample Pages to Discover More About the Report Offerings:
https://www.delveinsight.com/report-store/substance-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Substance Use Disorder Epidemiology
The epidemiology section covers detailed insights into the historical and current Substance Use Disorder patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Substance Use Disorder Epidemiology Segmentation
• Total Prevalent Cases of Substance Use Disorder (SUD)
• Severity-specific Prevalent Cases of SUD
• Diagnosed and Treatable Cases of Substance Use Disorder (SUD)
• Age-specific Prevalent Cases of Substance Use Disorder (SUD)
• Gender-specific Prevalent Cases of SUD
• Prevalent Cases of SUD based on substance type in the 7MM (e.g., alcohol, illicit drugs, or both)

Substance Use Disorder Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Substance Use Disorder market or expected to get launched in the market during the study period. The analysis covers Substance Use Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Substance Use Disorder Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Pipeline Development Activities:
https://www.delveinsight.com/sample-request/substance-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Some of the key companies in the Substance Use Disorder Market include:
• MediciNova
• Omeros Corp.
• KemPharm
• InterveXion Therapeutics
And many others

Substance Use Disorder Therapies covered in the report include:
• Ibudilast (MN-166)
• OMS405
• KP879
• IXT-m200
And many more

Learn More About the Emerging Therapies & Key Companies in the Substance Use Disorder Therapeutics Market:
https://www.delveinsight.com/sample-request/substance-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Substance Use Disorder Competitive Intelligence Analysis
4. Substance Use Disorder Market Overview at a Glance
5. Substance Use Disorder Disease Background and Overview
6. Substance Use Disorder Patient Journey
7. Substance Use Disorder Epidemiology and Patient Population
8. Substance Use Disorder Treatment Algorithm, Current Treatment, and Medical Practices
9. Substance Use Disorder Unmet Needs
10. Key Endpoints of Substance Use Disorder Treatment
11. Substance Use Disorder Marketed Products
12. Substance Use Disorder Emerging Therapies
13. Substance Use Disorder Seven Major Market Analysis
14. Attribute Analysis
15. Substance Use Disorder Market Outlook (7 major markets)
16. Substance Use Disorder Access and Reimbursement Overview
17. KOL Views on the Substance Use Disorder Market.
18. Substance Use Disorder Market Drivers
19. Substance Use Disorder Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Substance Use Disorder Market report here:
https://www.delveinsight.com/sample-request/substance-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Anuj Rawat
Email: info@delveinsight.com
https://www.delveinsight.com/

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.